Alternative devices can help when autoinjectors are unavailable

NewsGuard 100/100 Score

Autoinjectors are in especially high demand as the new school year begins. Reports of a shortage of EpiPens have been surfacing lately as parents attempt to stock up on the epinephrine autoinjectors for school, home, backpacks and grandma's house. The manufacturer of EpiPen, Mylan, has been dealing with manufacturing issues since May, and the device was placed on the Food and Drug Administration's (FDA) list of drug shortages.

The good news is that alternative devices are readily available. These include Auvi-Q and Adrenaclick. If you find that you are having issues filling your EpiPen prescription, call your allergist for help.

"Your allergist will be able to prescribe you an alternative autoinjector," explained Bradley Chipps, MD, FACAAI, president of the American College of Allergy, Asthma and Immunology (ACAAI). "They can also teach you how to use them, as each device works differently."

If you have expired autoinjectors and experience an anaphylactic reaction, it's better to use an expired device than nothing at all. However, with alternatives available, no one should have to rely on expired medication.

If you find yourself having trouble at the pharmacy, contact your allergist or, if you need help finding one, use the ACAAI allergist locator.​​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles